
Hexium
Advanced isotope enrichment technology for clean energy, nuclear medicine, and industrial applications with low capital costs.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor investor investor investor | €0.0 | round | |
* | N/A | $2.5m | Debt |
Total Funding | 000k |
Related Content
Hexium specializes in modernizing Atomic Vapor Laser Isotope Separation (AVLIS) technology for industrial-scale deployment, focusing initially on lithium enrichment. The company operates in the isotope enrichment market, serving sectors such as clean energy, nuclear medicine, and advanced industrial applications. Hexium's business model leverages a patent-pending approach that optimizes production output while utilizing existing supply chain infrastructure and modern laser designs to minimize capital and operating costs. Revenue is generated through the provision of enriched isotopes, which are essential for various high-impact sectors. The technology is financially viable, having been de-risked at a pilot scale with significant investment from the Department of Energy. Hexium's AVLIS technology offers flexibility and high selectivity, enabling efficient production of high-purity materials with minimal waste. Keywords: isotope enrichment, AVLIS, lithium, clean energy, nuclear medicine, industrial applications, laser technology, low costs, high purity, supply chain.